QbD Chair in Precision Oncology Research for Glioblastoma Renewed for Three More Years
- Home
- News & Events
- QbD Chair in Precision Oncology Research for Glioblastoma Renewed for Three More Years
QbD Chair in Precision Oncology Research for Glioblastoma Renewed for Three More Years
Wednesday, 17 January 2024
QbD Group
Share
\
\
X (Twitter) 
\
\
LinkedIn 
\
\
WhatsApp 
\
\
Copy link 
\
\
Mail
The QbD Chair supports the research of Professor Frederik De Smet on glioblastoma, an aggressive form of brain cancer. Behind the establishment of this chair lies a personal story.
.jpg?width=2048&height=1365&name=QbD%20Chair%20(1).jpg)
The personal story of the QbD Chair
Frederik De Smet, along with his two close friends, Bart Van Acker and Pieter Van Vlierberghe, studied bioengineering together. Bart founded the company QbD (Quality by Design), a consulting firm in life sciences. Frederik and Pieter became cancer researchers, one at KU Leuven and the other at UGent. Pieter specialized in pediatric leukemia and excelled in his field. A few years ago, he himself was diagnosed with an aggressive brain tumor, which proved fatal at the end of 2022. He was only 42 years old.
When Pieter received the diagnosis, he reached out to his former classmate Frederik, who was conducting research in his lab on better treatments for glioblastoma. Pieter and Frederik decided to collaborate and asked Bart Van Acker if he would financially support that research. And so, the ball started rolling. Unfortunately, Pieter did not benefit from the research himself, although he hoped that others after him would have better chances of recovery.
Frederik De Smet and his research team are working on making that hope a reality, supported by the QbD chair. After an initial three-year term, QbD decided to extend the chair for another three years. This extension was celebrated on January 11, 2024.
The idea of the chair came from Pieter, but we at QbD Group did not hesitate to say yes. At QbD Group, we support various social projects through our foundation. This chair is by far the largest project and holds a special place due to my personal connection with Pieter. He brought me and Frederik back together.
Bart Van Acker, CEO of QbD Group
The road to a successful treatment for aggressive brain tumors
The extension of the chair is a blessing for the research, which is a long-term endeavor. Glioblastoma is one of the most challenging forms of cancer to treat, with a survival rate of less than five percent over five years, despite intensive standard therapy. The harsh reality is that almost all clinical trials in the past twenty years have failed, attributed to the wide variety of patients and the heterogeneous nature of each individual tumor. This is why the financial boost from this chair is so crucial, says Frederik De Smet:
“Patronage allows us to develop new ideas and think outside the box. We use it to hire a doctoral student who explores avenues for which we do not receive research funding elsewhere.” The data generated by his team serves as a lever to win larger project grants. De Smet adds, “With the research data from the first term, we recently secured a large European grant of 12 million euros. We want to build on that momentum to bring better treatments for glioblastoma within reach.”
.jpg?width=900&height=600&name=QbD%20Chair%20(3).jpg)
Frederik and Bart were awarded a gift by the KU Leuven ©️Photographer Michael De Lausnay
Shoulder to shoulder, Bart Van Acker and Frederik De Smet continue the work, in memory of Pieter.
Find out all about patronage at KU Leuven and UZ Leuven here. Learn more about the QbD Chair here.
More latest news
Previous
9 Feb 2022
QbD Wallonia Expands: Welcoming a New Office and a Strengthened Team
QbD Wallonia proudly presents its brand-new office. The Belgian and international reference in...
27 Nov 2023
Bart Van Acker Establishes Chair to Combat Glioblastoma in Honor of Close Friend’s Battle with Aggressive Brain Tumor
Thanks to the QbD chair, Leuven professor Frederik De Smet is searching for better treatments for...
30 Mar 2023
QbD Group Foundation: Strengthening Our Commitment to Social Impact
QbD Group has been sponsoring many charities for years. To really embed our social commitment in a...
21 Jun 2024
Annual Update event on the QbD Research Chair for Precision Oncology Research in Glioblastoma
QbD Group held its 3rd annual event for an update on the QbD Chair, hosted at the beautiful Salons...
30 Aug 2023
Belgians Launch Miniature Heart into Space for Groundbreaking Aging Research
Five Belgian companies and research centres - including QbD Group - are joining forces in the...
9 Feb 2022
QbD Wallonia Expands: Welcoming a New Office and a Strengthened Team
QbD Wallonia proudly presents its brand-new office. The Belgian and international reference in...
27 Nov 2023
Bart Van Acker Establishes Chair to Combat Glioblastoma in Honor of Close Friend’s Battle with Aggressive Brain Tumor
Thanks to the QbD chair, Leuven professor Frederik De Smet is searching for better treatments for...
30 Mar 2023
QbD Group Foundation: Strengthening Our Commitment to Social Impact
QbD Group has been sponsoring many charities for years. To really embed our social commitment in a...
21 Jun 2024
Annual Update event on the QbD Research Chair for Precision Oncology Research in Glioblastoma
QbD Group held its 3rd annual event for an update on the QbD Chair, hosted at the beautiful Salons...
30 Aug 2023
Belgians Launch Miniature Heart into Space for Groundbreaking Aging Research
Five Belgian companies and research centres - including QbD Group - are joining forces in the...
9 Feb 2022
QbD Wallonia Expands: Welcoming a New Office and a Strengthened Team
QbD Wallonia proudly presents its brand-new office. The Belgian and international reference in...
27 Nov 2023
Bart Van Acker Establishes Chair to Combat Glioblastoma in Honor of Close Friend’s Battle with Aggressive Brain Tumor
Thanks to the QbD chair, Leuven professor Frederik De Smet is searching for better treatments for...
Next
- 1
- 2
- 3
Stay ahead in life sciences
Keeping up with the fast-paced life sciences industry doesn’t have to be overwhelming.
Our newsletter delivers the latest insights, industry updates, and expert content directly to your inbox, helping you stay informed and make smarter decisions.
Twitter Widget Iframe